![[up]](/style/images/multi_up.png)
Up a levelGroup by: Item Type | Date
Jump to: Journal article
Number of items: 4.
Journal article
Minja, Lilian Tina; Feltz, Isabella van der; Manyama, Christina; Mpagama, Stellah; Mhimbira, Francis; Noreña, Ivan; Sebe, Modulakgotla; Rassool, Mohammed; Wallis, Robert S.; Ntinginya, Nyanda; Liyoyo, Alphonce; Mbeya, Beno; Wagnerberger, Larissa; Zumba, Tresphory; Peter, Daud D.; Makkan, Heeran; Sloan, Derek J.; Brake, Lindsey te; Schildkraut, Jodie A; Aarnoutse, Rob; McHugh, Timothy D.; Wildner, Leticia; Boeree, Martin J.; Geiter, Lawrence; Cho, Young-Lag; Aldana, Brian H.; Phillips, Patrick P. J.; Hoelscher, Michael 
ORCID: https://orcid.org/0000-0002-7642-1835; Svensson, Elin M; Heinrich, Norbert; Hoelscher, Michael; Dreisbach, Julia; Wagnerberger, Larissa und Heinrich, Norbert ORCID: https://orcid.org/0000-0001-9252-7106
(2025):
Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trial.
In: Lancet Infectious Diseases, Vol. 25, No. 11: pp. 1219-1229
[PDF, 409kB]
ORCID: https://orcid.org/0000-0002-7642-1835; Svensson, Elin M; Heinrich, Norbert; Hoelscher, Michael; Dreisbach, Julia; Wagnerberger, Larissa und Heinrich, Norbert ORCID: https://orcid.org/0000-0001-9252-7106
(2025):
Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trial.
In: Lancet Infectious Diseases, Vol. 25, No. 11: pp. 1219-1229
[PDF, 409kB]
Heinrich, Norbert; de Jager, Veronique; Dreisbach, Julia; Gross-Demel, Petra; Schultz, Susanne; Gerbach, Sina; Kloss, Florian; Dawson, Rodney; Narunsky, Kim; Matt, Leoni; Wildner, Leticia; McHugh, Timothy D; Fuhr, Uwe; Aldana, Brian H; Mouhdad, Chaima; Brake, Lindsey te; Boeree, Martin J; Aarnoutse, Rob E; Svensson, Elin M; Gong, Xue; P J Phillips, Patrick; Diacon, Andreas H; Hoelscher, Michael; Hoelscher, Michael; Dreisbach, Julia; Gross – Demel, Petra; Wagnerberger, Larissa; Heinrich, Norbert; Razid, Alia; Lutchmun, Wandini; Noren᷉a, Ivan; Paramo Diaz, Laura; Sloan, Derek; Sabiiti, Wilber; Gillespie, Stephen; te Brake, Lindsey; Svensson, Elin; Mouhdad, Chaima; Aarnoutse, Rob; Boeree, Martin; Stemkens, Ralf; Koele, Simon; Bateson, Anna; Hunt, Robert; McHugh, Timothy Daniel; Muraro Wildner, Leticia; Solanki, Priya; Phillips, Patrick; Gong, Xue; Aldana, Brian; Crook, Angela; Dawson, Rodney; Narunsky, Kim; Arnolds, Shakeera; Diacon, Andreas; de Jager, Veronique; Friedrich, Sven; Sanne, Ian; Rassool, Mohammed; Churchyard, Gavin; Sebe, Modulakgotla; Makkan, Heeran; Mokaba, Lucia; Madikizela, Namhla; Mdluli, John; Sithole, Jane; Wallis, Robert; Beattie, Trevor; Ntinginya, Nyanda Elias; Mangu, Chacha; Manyama, Christina; Sabi, Issa; Mtafya, Bariki; Minja, Lilian Tina; Mhimbira, Francis; Mbeya, Benno; Zumba, Tresphory; Chibunu, Nyasige; Sasamalo, Mohamed; Reither, Klaus; Jugheli, Levan; Sam, Noel; Kibiki, Gibson; Semvua, Hadija; Mpagama, Stellah; Liyoyo, Alphonce; Adegbite, Bayode Romeo; Adegnika, Ayola Akim; Grobusch, Martin Peter; Kirenga, Bruce; Khosa, Celso; Timana, Isabel; Nliwasa, Marriott und Mukoka, Madalo
(2025):
Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial.
In: Lancet Microbe, Vol. 6, No. 2, 100952
[PDF, 589kB]
Svensson, Elin M.; Svensson, Robin J.; te Brake, Lindsey H. M.; Böree, Martin J.; Heinrich, Norbert; Konsten, Sarah; Churchyard, Gavin; Dawson, Rodney; Diacon, Andreas H.; Kibiki, Gibson S.; Minja, Lilian T.; Ntingiya, Nyanda E.; Saone, Ian; Gillespie, Stephen H.; Hölscher, Michael; Phillips, Patrick P. J.; Simonsson, Ulrika S. H. und Aarnoutse, Rob
(2018):
The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis.
In: Clinical Infectious Diseases, Vol. 67, No. 1: pp. 34-41
Boeree, Martin J.; Heinrich, Norbert; Aarnoutse, Rob; Diacon, Andreas H.; Dawson, Rodney; Rehal, Sunita; Kibiki, Gibson S.; Churchyard, Gavin; Sanne, Ian; Ntinginya, Nyanda E.; Minja, Lilian T.; Hunt, Robert D.; Charalambous, Salome; Hanekom, Madeleine; Semvua, Hadija H.; Mpagama, Stellah G.; Manyama, Christina; Mtafya, Bariki; Reither, Klaus; Wallis, Robert S.; Venter, Amour; Narunsky, Kim; Mekota, Anka; Henne, Sonja; Colbers, Angela; Plemper van Balen, Georgette; Gillespie, Stephen H.; Phillips, Patrick P. J. und Hölscher, Michael
(2017):
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.
In: Lancet infectious Diseases, Vol. 17, No. 1: pp. 39-49